ARTICLE | Clinical News
Yervoy ipilimumab regulatory update
November 11, 2013 8:00 AM UTC
Bristol-Myers said the European Commission approved an application to expand the label of Yervoy ipilimumab to include previously untreated patients with unresectable or metastatic melanoma. The human...